The two companies will collaborate to leverage their combined capabilities to set a roadmap for the future of vitamin K2.
Gnosis by Lesaffre (Lille, France), supplier of vitaMK7, acquired NattoPharma, supplier of MenaQ7. The two companies will collaborate to leverage their combined capabilities to set a roadmap for the future of vitamin K2.
“Vitamin K2 impacts every part of our lives,” said Gnosis by Lesaffre general manager Marc Philouze, in a press release. “From our joints to our arteries all the way down to our cells, vitamin K2 is essential for the function of several calcium-binding proteins that empower us to thrive as human beings. We’re proud to help satiate the global demand for this key ingredient by joining efforts with NattoPharma.”
“I am proud of the entrepreneurial journey accomplished by the NattoPharma team to build the vitamin K2 market and supporting science over the past decade,” added NattoPharma CEO Kjetil Ramsoy. “Lesaffre is recognized as a worldwide key player in the fermentation industry, leveraging innovation and industrial platforms to produce fermentation products; this, paired with NattoPharma’s expertise on the various forms of vitamin K2, makes us confident that we together will accelerate research and further explore K2 benefits as the true global leader in vitamin K2 with a full range of products meeting all customer needs.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.